Ann: Trading Halt, page-96

"I'm sure big pharma would be happy to pay good money to secure the rights to exploring the potential of this newly discovered mTor modulator (and the fifty odd analogues)"


https://biotuesdays.com/2019/08/12/pharmaust-readies-pivotal-trial-in-australia-to-treat-cancer-in-dogs/

We know our front office is not the fluff type IMO

From Roger Aston...

“We should have some results of the Phase 2 study in November or December this year and we’ll see where we go from there in terms of a human development program,” Roger Aston, executive chairman, says in an interview with BioTuesdays.
“If the canine study is successful, I don’t foresee any problem enticing a Big Pharma oncology company to license and develop monepantel for human use,” he adds. “A number of centers already have expressed an interest in looking at our compound as a treatment for cancer in humans based on the work we’ve done.”